# Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT）

Study · id `cardio:ct-nct06559241` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06559241](<https://clinicaltrials.gov/study/NCT06559241>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06559241

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2105 participants.

## Technical summary

Registry record NCT06559241. Randomized; single masking; primary purpose treatment. Start 2024-09-23 (actual); primary completion 2026-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 2105 participants (planned count; ClinicalTrials.gov record NCT06559241, source copy `cardio:ctgov-nct06559241-2026-11-09`, retrieved 2026-11-18)
- Started: 2024-09-23 (actual) (ClinicalTrials.gov record NCT06559241, source copy `cardio:ctgov-nct06559241-2026-11-09`, retrieved 2026-11-18)
- Primary completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT06559241, source copy `cardio:ctgov-nct06559241-2026-11-09`, retrieved 2026-11-18)
- Completion: 2027-02 (anticipated) (ClinicalTrials.gov record NCT06559241, source copy `cardio:ctgov-nct06559241-2026-11-09`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT06559241, source copy `cardio:ctgov-nct06559241-2026-11-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06559241-2026-11-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT）
- Acronym: RECAST-MT
- Condition: Acute Ischemic Stroke
- Condition: Anterior Circulation Brain Infarction
- Intervention (Device): 14-day remote ischemic conditioning
- Intervention (Device): 30-day remote ischemic conditioning
- Intervention (Procedure): Endovascular thrombectomy
- Intervention (Drug): Best medical management
- Lead sponsor: Capital Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Capital Medical University (`cardio:org-capital-medical-university`)

## Provenance

Content hash: 73c28b8a47c9c9e896bc321b79a4c41d93feaabfbc868a92a4e77df119d81afe
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
